Meet Frank


As a founder, what inspired you to create Crinetics? To be an expert in your field?
The passion for drug discovery, the trust and the compliment skill set among all founders inspired me to join the founding team.

What are your thoughts on the company during its creation compared to now?
During the last 11 years, We at Crinetics have grown up and proved to our patients, investors and peers that we are capable to discover and develop first in class and possibly best in class drug candidates targeting rare endocrine diseases. With Paltusotine moving to Phase III clinic trial for Acromegaly, it is exciting to see our founders’ original goal of making Crinetics a commercial company becomes closer and closer.

Read more >